Literature DB >> 20513078

Increased PD-L1 expression and PD-L1/CD86 ratio on dendritic cells were associated with impaired dendritic cells function in HCV infection.

Tao Shen1, Xiangmei Chen, Yu Chen, Qiang Xu, Fengmin Lu, Shuang Liu.   

Abstract

Impaired hepatitis C virus (HCV)-specific T cell immunity was associated with the persistence of HCV infection. Dysfunction of dentritic cells (DCs) was believed to be involved in T cell exhaustion, but the mechanisms were rarely understood. In this study, surface costimulatory marker (CD83, CD86, and CD40), coinhibitory marker (PD-L1) expression and allostimulatory capacity of plasmacytoid DCs (pDCs) and myeloid DCs (mDCs) were evaluated in HCV-infected patients. Results showed that the expression of both costimulatory and coinhibitory markers was increased in HCV-infected patients compared with healthy controls. PD-L1/CD86 ratio was increased and positively correlated with PD-L1 expression on DCs in HCV-infected patients. Allostimulatory capacity of DCs was impaired and inversely correlated with PD-L1 expression and PD-L1/CD86 ratio. These findings suggested that the effect of inhibitory marker PD-L1 overwhelmed the effect of costimulatory markers and down regulated DC-T activation in HCV-infected patients. The results will be helpful to understand the mechanism of dysfunction of DCs in HCV infection and shed light on the DC-based immunotherapeutic strategy. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20513078     DOI: 10.1002/jmv.21809

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  18 in total

1.  Rictor deficiency in dendritic cells exacerbates acute kidney injury.

Authors:  Helong Dai; Alicia R Watson; Daniel Fantus; Longkai Peng; Angus W Thomson; Natasha M Rogers
Journal:  Kidney Int       Date:  2018-09-04       Impact factor: 10.612

2.  Analyses of Pretherapy Peripheral Immunoscore and Response to Vaccine Therapy.

Authors:  Benedetto Farsaci; Renee N Donahue; Italia Grenga; Lauren M Lepone; Peter S Kim; Brendan Dempsey; Janet C Siebert; Nuhad K Ibrahim; Ravi A Madan; Christopher R Heery; James L Gulley; Jeffrey Schlom
Journal:  Cancer Immunol Res       Date:  2016-08-02       Impact factor: 11.151

Review 3.  Dendritic cell-based immunity and vaccination against hepatitis C virus infection.

Authors:  Yun Zhou; Ying Zhang; Zhiqiang Yao; Jonathan Patrick Moorman; Zhansheng Jia
Journal:  Immunology       Date:  2012-08       Impact factor: 7.397

4.  HCV viraemia associates with NK cell activation and dysfunction in antiretroviral therapy-treated HIV/HCV-co-infected subjects.

Authors:  E Papasavvas; L Azzoni; X Yin; Q Liu; J Joseph; A Mackiewicz; B Ross; K M Lynn; J M Jacobson; K Mounzer; J R Kostman; L J Montaner
Journal:  J Viral Hepat       Date:  2017-05-11       Impact factor: 3.728

5.  Dendritic cell co-stimulatory and co-inhibitory markers in chronic HCV: an Egyptian study.

Authors:  Hanan Fouad; Maissa Saeed El Raziky; Rasha Ahmed Abdel Aziz; Dina Sabry; Ghada Mahmoud Abdel Aziz; Manal Ewais; Ahmed Reda Sayed
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

Review 6.  Dendritic cells: The warriors upfront-turned defunct in chronic hepatitis C infection.

Authors:  Meenakshi Sachdeva; Yogesh K Chawla; Sunil K Arora
Journal:  World J Hepatol       Date:  2015-09-08

7.  Increased expression of programmed death (PD)-1 and its ligand PD-L1 correlates with impaired cell-mediated immunity in high-risk human papillomavirus-related cervical intraepithelial neoplasia.

Authors:  Wen Yang; Yan Song; Yun-Long Lu; Jun-Zhong Sun; Hong-Wei Wang
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

8.  Dominating expression of negative regulatory factors downmodulates major histocompatibility complex Class-II expression on dendritic cells in chronic hepatitis C infection.

Authors:  Shallu Tomer; Yogesh K Chawla; Ajay Duseja; Sunil K Arora
Journal:  World J Gastroenterol       Date:  2016-06-14       Impact factor: 5.742

9.  An unbalanced PD-L1/CD86 ratio in CD14(++)CD16(+) monocytes is correlated with HCV viremia during chronic HCV infection.

Authors:  Jiajia Zheng; Hua Liang; Chunhui Xu; Qiang Xu; Ting Zhang; Tao Shen; Fengmin Lu
Journal:  Cell Mol Immunol       Date:  2014-02-17       Impact factor: 11.530

10.  HIV-1 Tat protein induces PD-L1 (B7-H1) expression on dendritic cells through tumor necrosis factor alpha- and toll-like receptor 4-mediated mechanisms.

Authors:  Rémi Planès; Lbachir BenMohamed; Kaoutar Leghmari; Pierre Delobel; Jacques Izopet; Elmostafa Bahraoui
Journal:  J Virol       Date:  2014-04-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.